DrugSep 20, 2017
Ninjacof recall — FDA D-1140-2017
Microbial contamination of Non-sterile Products; potential B. cepacia contamination
Class IIFDA: TerminatedCenturion Labs, LLC
10,690drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 234
10,690 detailed records are currently available in this category.
DrugSep 20, 2017
VistaPharm Hydrocodone Bitartrate and Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mL recall — FDA D-1139-2017
Labeling: Not Elsewhere Classified; product is incorrectly labeled as Class III controlled substance instead of Class II controlled substance
Class IIIFDA: TerminatedVistaPharm, Inc.
DrugSep 20, 2017
MEDLINE INDUSTRIES Vitamin A&D Ointment (petroleum 93.5%), Skin Protectant, NET Wt. 0.18 OZ recall — FDA D-1138-2017
Labeling Mixup; the individual A&D ointment foil packets are incorrectly labeled as petroleum jelly. The boxes and outer case are correctly labeled as A&D ointment.
Class IIFDA: TerminatedMEDLINE INDUSTRIES Inc.
DrugSep 20, 2017
Mid Valley Pharmaceutical Doctor Manzanilla Cough & Cold recall — FDA D-1136-2017
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
Class IIFDA: TerminatedMid Valley Pharmaceutical
DrugSep 20, 2017
BESTHERBS COFFEE New Kopi Jantan Tradisional Natural Herbs Coffee recall — FDA D-1144-2017
Marketed without an approved NDA/ANDA: presence of undeclared desmethyl carbodenafil and undeclared milk.
Class IFDA: TerminatedBESTHERBS COFFEE LLC
DrugSep 20, 2017
Paroxetine tablets USP, 30mg, 30-count bottles recall — FDA D-1137-2017
Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets
Class IIFDA: TerminatedZydus Pharmaceuticals USA Inc.
DrugSep 13, 2017
Degasa Sa De Cv Povidone Iodine, USP Prep Solution, 10% recall — FDA D-1129-2017
Labeling: Label mix-up. Finished product Povidone iodine 7.5% was labeled as Povidone iodine 10% , the outer box had the correct label.
Class IIFDA: TerminatedDegasa Sa De Cv
DrugSep 13, 2017
ImprimisRx CA, Inc., dba ImprimisRx Latanoprost PF Solution, 0.005%, Ophthalmic Drops in recall — FDA D-1131-2017
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Class IIFDA: TerminatedImprimisRx CA, Inc., dba ImprimisRx
DrugSep 13, 2017
ImprimisRx CA, Inc., dba ImprimisRx Timolol-Latanoprost PF Solution (0.5-0.005)%, Ophthalmic recall — FDA D-1132-2017
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Class IIFDA: TerminatedImprimisRx CA, Inc., dba ImprimisRx
DrugSep 13, 2017
ImprimisRx CA, Inc., dba ImprimisRx Timolol-Brimonidine-Dorzolamide-Latanoprost recall — FDA D-1133-2017
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Class IIFDA: TerminatedImprimisRx CA, Inc., dba ImprimisRx
DrugSep 13, 2017
ImprimisRx CA, Inc., dba ImprimisRx Curcumin Emulsion 10mg/ml Injection, Sterile 10 mL recall — FDA D-1130-2017
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Class IIFDA: TerminatedImprimisRx CA, Inc., dba ImprimisRx
DrugSep 13, 2017
Mckesson Packaging Services Propafenone Hydrochloride tablets, 150 mg recall — FDA D-1128-2017
Failed moisture limits: Out of specification for moisture content.
Class IIIFDA: TerminatedMckesson Packaging Services
DrugSep 6, 2017
Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL) recall — FDA D-1126-2017
Defective container: Oral solution leaking from container.
Class IIFDA: TerminatedTris Pharma Inc.
DrugSep 6, 2017
Morton Grove Pharmaceuticals Amoxicillin and Clavulanate Potassium for Oral Suspension, USP recall — FDA D-1125-2017
Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.
Class IIFDA: TerminatedMorton Grove Pharmaceuticals, Inc.
DrugSep 6, 2017
Amphastar Pharmaceuticals Ketorolac Tromethamine Injection, USP 30 mg/mL recall — FDA D-1124-2017
Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.
Class IIFDA: TerminatedAmphastar Pharmaceuticals, Inc.
DrugAug 30, 2017
The Harvard Drug Group Rugby Diocto Syrup, Docusate Sodium 60 mg/15 mL, Stool Softener recall — FDA D-1120-2017
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Class IIFDA: TerminatedThe Harvard Drug Group
DrugAug 30, 2017
The Harvard Drug Group Rugby Diocto Liquid, Docusate Sodium 50 mg/ 5 mL, Stool Softener recall — FDA D-1119-2017
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Class IIFDA: TerminatedThe Harvard Drug Group
DrugAug 30, 2017
The Harvard Drug Group Rugby Aller-chlor recall — FDA D-1122-2017
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Class IIFDA: TerminatedThe Harvard Drug Group
DrugAug 30, 2017
Phentermine Capsules, 15 mg, a) 7-count bottle (NDC 55289-791-07), b) 14-count bottle recall — FDA D-1118-2017
Failed Impurities/Degradation Specifications:Out of specification results for individual unknown impurities at 30th month Room Temperature Retained Sample stabilities test .
Class IIIFDA: TerminatedPD-Rx Pharmaceuticals, Inc.
DrugAug 30, 2017
The Harvard Drug Group Major Senna Syrup Natural Vegetable Laxative, Sennoside 8.8 mg, 8 fl. recall — FDA D-1121-2017
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Class IIFDA: TerminatedThe Harvard Drug Group
DrugAug 30, 2017
The Harvard Drug Group Rugby Senexon Liquid Natural Vegetable Stimulant,(Sennosides) 8.8 mg recall — FDA D-1123-2017
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Class IIFDA: TerminatedThe Harvard Drug Group
DrugAug 30, 2017
C. O. Truxton Phenobarbital Tablets USP, 15 mg, 1000 count bottles recall — FDA D-1111-2017
Labeling: Labeled Error on Declared Strength; report of a 1000 ct bottle labeled as Phenobarbital 15 mg tablets actually contained 30 mg tablets
Class IFDA: TerminatedC. O. Truxton
DrugAug 23, 2017
Entecavir Tablets 0.5 mg, 30 tablets per container recall — FDA D-1095-2017
Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.
Class IIFDA: TerminatedHetero USA Inc.
DrugAug 23, 2017
Linde Eckstein Gmbh + Co KG Beautipharm Body Moisturizing Balm SPF 10 recall — FDA D-1098-2017
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Class IIIFDA: TerminatedLinde Eckstein Gmbh + Co KG
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.